Similar Articles
1381 Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in Taiwan
1382 Transarterial embolization of metastatic mediastinal hepatocellular carcinoma
1383 Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases
1384 Is the American Association for the Study of Liver Diseases recommendation for hepatocellular carcinoma screening a cul-de-sac?
1385 High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients
1386 Strategies to reduce hepatitis C virus recurrence after liver transplantation
1387 Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma
1388 Mycotoxins are conventional and novel risk biomarkers for hepatocellular carcinoma
1389 Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma
1390 Hepatocellular carcinoma in patients with chronic kidney disease
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA